Abacavir

Sold as Septadine antiseptic, Ziagen, Invertron, Bavir, Cipla-abacavir, Abamune, Cipla abacavir, Aspen abacavir, Adco-abacavir, Abavaid, Adco abacavir, Propan abacavir, Kavimun paed, Abacavir specpharm, Kavimun, Hetacav, Abacavir sandoz, Bacamune, Sonke abacavir

C₁₄H₁₈N₆O286.33 g/mol

[(1S,4R)-4-[2-Amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol

Drag to rotate. Structure from PubChem CID 441300.

Loading Wikipedia summary

Registration

Applicants: 12
Registrations: 24
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd	Septadine antiseptic	100 ml	280650	S4	PI PIL
Glaxosmithkline South Africa (Pty) LimitedCancelled	Ziagen	tablets, oral solution	330464, 330465	S4	None
Novagen Pharma (Pty) LtdCancelled	Invertron	20 mg/ml, 300 mg	410248, 410386	S4	None
Aurobindo Pharma (Pty) Ltd1 of 2 cancelled	Bavir	20 mg/ml, 300 mg	410387, 410917	S4	None
Cipla Medpro (Pty) LtdCancelled	Cipla-abacavir, Abamune	300, oral solution	410692, 410856	S4	None
Cipla Medpro Manufacturing (Pty) Ltd	Cipla abacavir	oral solution	410857	S4	None
Pharmacare limited û woodmeadCertificate held by Pharmacare limited	Aspen abacavir	20 mg/ml, 300 mg	410988, 430724	S4	PI PIL
Adcock ingram limited1 of 4 cancelled	Adco-abacavir, Abavaid, Adco abacavir, Propan abacavir	tablets, solution	430386, 450909, 450910, 450911	S4	None
Viatris Healthcare (Pty) Ltd	Kavimun paed, Kavimun	Not stated	460006, 460979	S4	None
Specpharm (Pty) LtdCancelled	Abacavir specpharm	20	460024	S4	None
Hetero Drugs South Africa (Pty) Ltd	Hetacav, Abacavir sandoz, Bacamune	20 mg/ml, oral solution, 300	480342, 480369, 510304, 510305.304	S4	None
Ranbaxy Pharmaceutical (Pty) Ltd	Sonke abacavir	300	A400777	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Septadine oral antiseptic*	100 mlSolution	28065028/16.4/0650Approved 24 August 2022	Registered	S4	PI PIL
Ziagen tablets EACH TABLET CONTAINS ABACAVIR 300,0 mg	Tablets	33046433/20.2.8/0464	Cancelled	S4	None
Ziagen oral solution EACH 1,0 ml SOLUTION CONTAINS ABACAVIR 20,0 mg	Oral solution	33046533/20.2.8/0465	Cancelled	S4	None
Invertron tablets 300 MG EACH TABLET CONTAINS ABACAVIR 300,0 mg	300 mgTablets	41024841/20.2.8/0248	Cancelled	S4	None
Invertron oral solution 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS ABACAVIR SULPHATE EQUIVALENT TO ABACAVIR 20,0 mg	20 mg/mlOral solution	41038641/20.2.8/0386	Cancelled	S4	None
Bavir oral solution 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS ABACAVIR SULPHATE EQUIVALENT TO ABACAVIR 20,0 mg	20 mg/mlOral solution	41038741/20.2.8/0387	Registered	S4	None
Cipla-abacavir 300 EACH TABLET CONTAINS ABACAVIR 300,0 mg	300	41069241/20.2.8/0692	Cancelled	S4	None
Abamune oral solution EACH 1,0 ml SOLUTION CONTAINS ABACAVIR 20,0 mg	Oral solution	41085641/20.2.8/0856	Cancelled	S4	None
Cipla abacavir oral solution EACH 1,0 ml SOLUTION CONTAINS ABACAVIR 20,0 mg	Oral solution	41085741/20.2.8/0857	Registered	S4	None
Bavir tablets 300 MG EACH TABLET CONTAINS ABACAVIR 300,0 mg	300 mgTablets	41091741/20.2.8/0917	Cancelled	S4	None
Aspen abacavir 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS ABACAVIR 20,0 mg	20 mg/ml	41098841/20.2.8/0988	Registered	S4	None
Adco-abacavir tablets EACH TABLET CONTAINS ABACAVIR 300,0 mg	Tablets	43038643/20.2.8/0386	Registered	S4	None
Aspen abacavir 300 EACH TABLET CONTAINS ABACAVIR 300,0 mg	300 mgFilm-coated tablets	43072443/20.2.8/0724Approved 2 July 2017	Registered	S4	PI PIL
Abavaid solution EACH 1,0 ml CONTAINS ABACAVIR 20,0 mg	Solution	45090945/20.2.8/0909	Registered	S4	None
Adco abacavir solution EACH 1,0 ml CONTAINS :ABACAVIR SULPHATE EQUIVALENT TO ABACAVIR 20,0 mg	Solution	45091045/20.2.8/0910	Registered	S4	None
Propan abacavir solution EACH 1,0 ml CONTAINS ABACAVIR 20,0 mg	Solution	45091145/20.2.8/0911	Cancelled	S4	None
Kavimun paed EACH TABLET CONTAINS ABACAVIR 60,0 mg	Not listed	46000646/20.2.8/0006	Registered	S4	None
Abacavir specpharm 20 EACH 1,0 ml OF SOLUTION CONTAINS ABACAVIR 20,0 mg	20	46002446/20.2.8/0024	Cancelled	S4	None
Kavimun EACH TABLET CONTAINS ABACAVIR 300,0 mg	Not listed	46097946/20.2.8/0979	Registered	S4	None
Hetacav oral solution 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS ABACAVIR 20,0 mg	20 mg/mlOral solution	48034248/20.2.8/0342	Registered	S4	None
Abacavir sandoz oral solution EACH 1,0 ml SOLUTION CONTAINS ABACAVIR 20,0 mg	Oral solution	48036948/20.2.8/0369	Registered	S4	None
Hetacav 300 EACH TABLET CONTAINS :ABACAVIR SULPHATE EQUIVALENT TO ABACAVIR 300,0 mg	300	51030451/20.2.8/0304	Registered	S4	None
Bacamune 300 EACH TABLET CONTAINS ABACAVIR 300,0 mg	300	510305.30451/20.2.8/0305.304	Registered	S4	None
Sonke abacavir 300 EACH TABLET CONTAINS: ABACAVIR 300,0 mg	300	A400777A40/20.2.8/0777	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Abacavir sulphate

S4: Abacavir
Consolidated Schedules 06 July 2026, line 5118

Pharmacological class: Naso-pharyngeal and bucco-pharyngeal antiseptics. (class 16.4)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsSeptadine oral antiseptic*, Ranbaxy (SA) (Pty) Ltd Patient information leaflet (PIL)For patients and carersSeptadine oral antiseptic*, Ranbaxy (SA) (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background